📍 Whitefield, Bengaluru
HOD & Senior Consultant · Surgical Oncology
Consultation by Appointment
Hearing the words “you have breast cancer” changes everything in a moment. Most patients are too overwhelmed in the first consultation to ask everything they want to know, and the questions come later: at 2 a.m., in the hospital car park, or when a relative asks something you cannot answer. We hear these questions every day, and we have answered them here in the words patients actually use.
On this page, you will find answers about:
These answers describe what is typical for most patients. Your own oncologist knows your case best and may advise differently.
Jump to: First questions | Your report | Treatment plan | Surgery | Chemotherapy | Radiation | Hormone and targeted therapy | Family, genetics, fertility | Diet and lifestyle | Cost and insurance | After treatment | If cancer has spread
Most breast cancers found before they have spread to distant organs (stages 0 to III) are treated with the goal of cure, and the majority of these patients are alive and well many years after diagnosis.
| Stage Group at Diagnosis | Treatment Goal | Approximate 5-Year Relative Survival* |
|---|---|---|
| Localised (confined to the breast) | Cure | About 99% |
| Regional (spread to nearby lymph nodes or tissue) | Cure, usually with combined treatment | About 87% |
| Distant (metastatic, stage IV) | Long-term control and quality of life | About 32%, and improving with newer drugs |
| All stages combined | — | About 91% |
*US SEER data for patients diagnosed 2014–2020. These are population averages and cannot predict any individual’s outcome. Survival in India varies with stage at diagnosis and access to treatment.
Your final stage is usually confirmed once the biopsy, receptor tests, imaging and, in many cases, surgery results are available, which typically takes 1 to 3 weeks.
| Test | What It Tells Us | Typical Time to Result |
|---|---|---|
| Core needle biopsy | Confirms cancer, its type and grade | 3–5 working days |
| Receptor tests (ER, PR, HER2, Ki-67) | Cancer subtype; guides drug choice | 3–7 working days after biopsy |
| HER2 FISH test (if HER2 is 2+) | Confirms borderline HER2 status | 5–10 working days |
| Staging scans (CT, bone scan or PET-CT) | Whether cancer has spread beyond the breast | Scan within a few days; report in 1–2 days |
| Genetic (BRCA) testing | Whether you carry an inherited cancer gene | 2–4 weeks |
| Genomic test (e.g., Oncotype DX) | Whether chemotherapy is likely to help in selected hormone-positive cancers | About 2–3 weeks |
| Surgical pathology | Exact tumour size, margins and lymph node status | 5–10 working days after surgery |
How quickly a breast cancer grows depends on its grade, Ki-67 score and receptor subtype, and faster-growing subtypes often respond well to modern treatment.
For most patients, taking 2 to 4 weeks to complete tests, get a second opinion and plan treatment is considered safe, and guidelines generally aim for treatment to begin within about 4 to 6 weeks of diagnosis.
In most cases, breast cancer cannot be traced back to any single thing a person did or did not do, and many women who are diagnosed have no known risk factor other than being female and getting older.
| Common Worry | What Current Evidence Shows |
|---|---|
| Stress caused my cancer | No consistent evidence that stress causes breast cancer |
| Wearing an underwire or tight bra | No evidence of a link |
| Using deodorant or antiperspirant | No link found in large studies |
| A hit or injury to the breast | Not shown to cause cancer; it may draw attention to a lump already present |
| Something I ate in the past | No single food has been shown to cause breast cancer |
Current evidence shows that the risk of a needle biopsy spreading breast cancer is extremely low, and biopsy has not been linked to worse survival.
Many breast cancer patients do not need a PET-CT scan; for small, early-stage cancers without symptoms, guidelines generally do not recommend full-body scans because the chance of spread is low.
Hormone receptor-positive, HER2-negative breast cancer is the most common subtype and is generally associated with a favourable outlook, as it can be treated with hormone therapy.
| If Your Report Says | What It Usually Means for Treatment |
|---|---|
| ER+ and/or PR+ | Hormone therapy tablets are usually recommended for 5–10 years |
| HER2-positive (3+, or 2+ with positive FISH) | HER2-targeted drugs such as trastuzumab are usually recommended; these have substantially improved survival |
| HER2-low (1+, or 2+ with negative FISH) | Mainly relevant if the cancer spreads, when newer drugs may be options |
| Triple-negative (ER−, PR−, HER2−) | Chemotherapy is usually the main treatment, sometimes with immunotherapy; genetic testing is advised |
| High Ki-67 | Cells are dividing quickly; chemotherapy is more likely to be recommended |
Triple-negative breast cancer has a higher risk of recurrence in the first few years, but it often responds well to chemotherapy, and the risk of recurrence falls considerably for patients who remain cancer-free after about 5 years.
Breast cancer includes several different subtypes, so two people with breast cancer may need very different treatment based on stage, receptor status, genetics and overall health.
Seeking a second opinion is a normal and widely accepted part of cancer care, and most oncologists welcome it.
Many women with early breast cancer can keep their breast with breast-conserving surgery (lumpectomy) followed by radiation, which long-term studies show offers similar survival to mastectomy for suitable patients.
| Situation | Usual Surgical Option |
|---|---|
| Small tumour compared with breast size | Breast-conserving surgery (lumpectomy) |
| Large tumour that shrinks well with chemotherapy first | Breast conservation may become possible |
| Several tumours in different parts of the breast | Mastectomy is often advised |
| BRCA mutation carrier | Mastectomy is often discussed; breast conservation may still be an option |
| Mastectomy needed, but you want a breast shape | Reconstruction at the same time or later |
For women without a high-risk inherited gene mutation, removing the healthy breast has not been shown to improve survival, because the risk of a new cancer in the other breast is generally low.
Chemotherapy after surgery aims to destroy microscopic cancer cells that may have spread beyond the breast but are too small to see on scans, which lowers the risk of the cancer returning.
For suitable patients, chemotherapy before surgery (neoadjuvant chemotherapy) gives similar overall survival to chemotherapy after surgery, with some added practical advantages.
Some patients can safely avoid chemotherapy or radiation when their oncologist confirms that the expected benefit for their specific cancer is very small.
Active breast cancer treatment typically takes about 6 to 12 months, and patients with hormone-positive cancer usually continue hormone therapy tablets for 5 to 10 years.
| Treatment Phase | Typical Duration | How Often You Visit |
|---|---|---|
| Tests and planning | 1–3 weeks | Several visits |
| Chemotherapy (if needed) | 3–6 months | Every 1–3 weeks |
| Surgery and recovery | 2–6 weeks | Hospital stay of 1–3 days; wound check in 1–2 weeks |
| Radiation therapy | 1–3 weeks (some schedules are longer) | Daily, Monday to Friday |
| HER2-targeted therapy | About 1 year in total | Every 3 weeks |
| Hormone therapy tablets | 5–10 years | Daily tablet; review every 3–12 months |
Your plan may include only some of these phases, in a different order.
Alternative medicines should not be used in place of proven breast cancer treatment, and some herbal products can interact with cancer drugs or affect the liver, so tell your oncologist before taking them.
There is no reliable evidence that surgery causes breast cancer to spread; surgery is one of the most important treatments for curing breast cancer.
Many patients now need only 1 to 3 lymph nodes removed (sentinel lymph node biopsy), which keeps the risk of long-term arm swelling relatively low.
| Procedure | Nodes Usually Removed | Approximate Risk of Lymphoedema |
|---|---|---|
| Sentinel lymph node biopsy | 1–3 | About 5% |
| Axillary lymph node dissection | Often 10 or more | About 15–25% |
Most patients go home within 1 to 3 days after breast cancer surgery and resume light daily activities within about 1 to 2 weeks.
| Activity | When It Is Usually Possible |
|---|---|
| Walking and light household work | The next day |
| Showering | Often within 2–3 days, once your surgeon allows |
| Wound check and drain review | 7–14 days after surgery |
| Office or desk work | 1–3 weeks |
| Driving | 1–2 weeks, once off strong painkillers and able to turn the wheel comfortably |
| Lifting heavy objects or strenuous exercise | 4–6 weeks |
| After reconstruction | Add about 2–6 weeks to these times |
Your surgeon will confirm timings for your specific operation.
A drain is often placed after mastectomy or lymph node surgery to remove fluid, and it is usually removed within 1 to 2 weeks once the daily output falls to a level your surgeon considers safe.
Many women can have breast reconstruction during the same operation as their mastectomy, while others choose, or are advised, to have it later.
Most chemotherapy regimens used for breast cancer cause hair loss, which usually begins 2 to 3 weeks after the first cycle, and in most patients hair begins to regrow within 1 to 3 months of finishing chemotherapy.
| Time | What Usually Happens |
|---|---|
| 2–3 weeks after the first cycle | Scalp may feel tender; hair starts to fall |
| By the 2nd or 3rd cycle | Most scalp hair is lost; eyebrows and lashes may thin |
| 1–3 months after the last cycle | Soft new growth begins |
| 3–6 months after the last cycle | Short, fuller hair for many patients; texture or colour may differ at first |
| 6–12 months after the last cycle | Hair continues to thicken |
With modern anti-nausea medicines, most breast cancer patients have little or manageable vomiting during chemotherapy.
Side effects usually follow a predictable pattern within each chemotherapy cycle, with most patients feeling their lowest in the first week and recovering before the next dose.
| Days After Chemotherapy | How You May Feel | What Helps |
|---|---|---|
| Days 1–3 | Nausea, tiredness, poor appetite | Anti-nausea medicines on schedule; small meals; plenty of fluids |
| Days 4–7 | Fatigue peaks; body aches; taste changes | Rest; short walks; soft, bland foods |
| Days 7–14 | White cell count at its lowest; infection risk highest | Avoid crowds and sick contacts; check your temperature if unwell |
| Days 14–21 | Energy returns as blood counts recover | Plan work, errands and social activities |
Based on a typical 3-weekly regimen; weekly schedules follow a different pattern.
A temperature of 38°C (100.4°F) or higher during chemotherapy should be treated as a medical emergency, because it may signal a serious infection when your white blood cell count is low.
| Symptom | What to Do | How Urgent |
|---|---|---|
| Fever of 38°C (100.4°F) or above, or chills and shivering | Go to the emergency department or call the oncology helpline | Immediately |
| Breathlessness, chest pain or a racing heartbeat | Go to the emergency department | Immediately |
| Bleeding, black stools or unusual bruising | Call the oncology helpline or go to emergency | Immediately |
| Confusion, severe drowsiness or fainting | Go to the emergency department | Immediately |
| Painful swelling in one arm or leg | Call your team for same-day assessment | Same day |
| Vomiting or diarrhoea that does not stop, or you cannot keep fluids down | Call your team | Same day |
| Mouth ulcers that stop you eating or drinking | Call your team | Within 24 hours |
Do not take paracetamol to lower a fever before contacting your team unless advised, as it can mask an infection. Keep your oncology team’s emergency contact number with you at all times.
In general, it is safe to hug, hold and spend time with children and grandchildren during chemotherapy, with a few simple precautions.
During chemotherapy, the priorities are eating enough protein and calories and following food-safety precautions, as your immunity may be reduced.
| Choose | Avoid |
|---|---|
| Freshly cooked, hot home food | Street food, roadside chaat and cut fruit from vendors |
| Well-cooked eggs, meat, fish and dal | Raw or undercooked eggs, meat or fish |
| Boiled or filtered water | Unfiltered water and ice of unknown source |
| Pasteurised milk, curd and paneer | Unpasteurised dairy |
| Fruits you wash and peel yourself | Herbal juices and supplements not approved by your oncologist |
Many patients continue working during chemotherapy, often with reduced hours or remote work in the days after each cycle.
When chemotherapy is given before surgery, your oncologist monitors its effect through examination and imaging; when it is given after surgery, there is no visible tumour to measure, and its benefit lies in lowering the risk of recurrence.
Many patients notice changes in memory and concentration during and after chemotherapy, and for most people these improve gradually over months.
External beam radiation, the most common type used for breast cancer, does not make you radioactive, so it is safe to hug, cook for and sleep near your family, including children and pregnant women.
Breast radiation usually involves one planning visit followed by about 5 to 15 daily treatments over 1 to 3 weeks, with each session lasting about 10 to 20 minutes, although some patients need longer schedules.
| Stage | What Happens | Duration |
|---|---|---|
| Planning (simulation) scan | CT scan in treatment position; small skin marks; breath-hold practice if needed | One visit of 30–60 minutes |
| Plan preparation | Doctors and physicists design your treatment plan | About 3–10 days |
| Daily treatment | Painless radiation delivery on a treatment machine | 10–20 minutes per visit, Monday to Friday |
| Weekly review | Your doctor checks your skin and side effects | Once a week |
| After the last session | Skin reaction may peak | 1–2 weeks after treatment ends |
| Recovery | Skin heals and tiredness eases | Usually 2–4 weeks |
Radiation treatment itself is painless, but the treated skin may gradually become red, dry or itchy, similar to a sunburn, towards the end of treatment.
You can usually bathe daily during radiation, and many centres now allow deodorant on unbroken skin; follow your own radiation team’s advice.
Mild to moderate tiredness is common during and for a few weeks after radiation, and the treated breast may become slightly firmer, smaller or darker over time.
Hormone therapy tablets such as tamoxifen or letrozole substantially reduce the risk of hormone-positive breast cancer returning, and stopping early may reduce this protection.
Hot flushes and joint pain are common side effects of hormone therapy, while large studies have not shown a strong direct link between these tablets and significant weight gain.
| Side Effect | What May Help |
|---|---|
| Hot flushes and night sweats | Layered clothing, avoiding triggers, certain non-hormonal medicines |
| Joint and muscle pain (mainly aromatase inhibitors) | Regular exercise, walking, yoga, painkillers, switching tablets |
| Vaginal dryness | Non-hormonal moisturisers and lubricants |
| Bone thinning (aromatase inhibitors) | Bone density scans, calcium, vitamin D, weight-bearing exercise, bone-protecting medicines |
| Low mood or mood changes | Counselling, support groups, medical treatment where needed |
Trastuzumab biosimilars approved by regulators have shown comparable effectiveness and safety to the original brand in clinical trials, usually at a lower cost.
Having a mother or sister with breast cancer increases a woman’s risk, but most relatives of breast cancer patients do not develop the disease.
| Your Result or Situation | Usual Advice for Relatives |
|---|---|
| No inherited mutation found | Screening based on family history, often starting about 10 years before your age at diagnosis |
| BRCA1, BRCA2 or similar mutation found | Adult relatives are offered genetic counselling and testing |
| A relative tests positive | Earlier MRI and mammogram screening, and discussion of preventive options |
Many women have healthy pregnancies after breast cancer, and current studies suggest that pregnancy after treatment does not increase the risk of recurrence.
| Fertility Option | When It Is Done | Key Points |
|---|---|---|
| Egg freezing | Before chemotherapy; takes about 2 weeks | Does not require a partner |
| Embryo freezing | Before chemotherapy; takes about 2 weeks | Requires partner or donor sperm |
| GnRH agonist injections | During chemotherapy | May help protect ovarian function |
| Ovarian tissue freezing | Before chemotherapy, in selected cases | Available at specialist centres |
| Pausing hormone therapy to conceive | After about 18–30 months of hormone therapy, under supervision | Studied in the international POSITIVE trial |
Pregnancy should be avoided during breast cancer treatment, as chemotherapy, radiation, hormone therapy and targeted drugs can harm a developing baby.
Sexual intimacy is generally safe during breast cancer treatment, although changes in desire, comfort and body image are common and can be addressed.
Children usually cope better when they are given honest, age-appropriate information rather than sensing that something is being hidden.
There is no evidence that eating sugar directly makes breast cancer grow faster, because all cells in the body, healthy or cancerous, use glucose for energy.
No single food has been shown to cure or cause breast cancer; a balanced diet with adequate protein, vegetables, fruits and whole grains is generally recommended during and after treatment.
| Food Question | What Current Evidence Suggests |
|---|---|
| Should I stop eating non-veg? | Not necessary; eggs, fish and chicken are good protein sources. Limit red and processed meat |
| Is milk or curd harmful? | Dairy is generally safe and provides protein and calcium |
| Is soy (tofu, soya chunks) safe? | Moderate amounts of soy foods appear safe for breast cancer patients |
| Will papaya leaf juice, wheatgrass or turmeric cure cancer? | No proven anti-cancer benefit; some supplements may interact with treatment |
| Is alkaline water or a special “cancer diet” helpful? | Not supported by scientific evidence |
| Can I drink alcohol? | Best limited or avoided, as alcohol is linked to higher breast cancer risk |
Strict fasting, especially without water, is generally not advised on chemotherapy days or when blood counts are low, but modified fasting may be possible with your oncologist’s guidance.
Regular exercise is safe for most breast cancer patients, can reduce fatigue and improve mood, and is linked with a lower risk of recurrence.
Most everyday activities, including travel and social events, are possible during breast cancer treatment with some planning around your treatment cycles and blood counts.
The cost of breast cancer treatment varies mainly with stage, subtype and the drugs required, and you should ask for a written estimate before treatment begins.
| Treatment Component | Relative Cost | Notes |
|---|---|---|
| Tests, biopsy and scans | Low to moderate | Higher if PET-CT or genetic tests are needed |
| Surgery | Moderate | Higher with reconstruction |
| Standard chemotherapy | Moderate | Depends on the number of cycles |
| Radiation therapy | Moderate | Shorter schedules may reduce overall cost |
| Hormone therapy tablets | Low | Taken for years but relatively inexpensive |
| HER2-targeted drugs, immunotherapy, CDK4/6 inhibitors | High | Biosimilars and patient assistance programmes may reduce cost |
Most health insurance policies in India cover breast cancer surgery, chemotherapy and radiation, and eligible patients may be covered under Ayushman Bharat PM-JAY or state health schemes, although terms vary.
| What to Check | Why It Matters |
|---|---|
| Day-care chemotherapy cover | Chemotherapy is usually given without an overnight stay |
| Sub-limits and co-payment clauses | These may cap payment for costly drugs or procedures |
| Cover for oral anti-cancer drugs | Hormone tablets and CDK4/6 inhibitors may not be covered |
| Pre-authorisation requirements | Delays in approval can postpone treatment dates |
| Room-rent limits | These can proportionally reduce the whole claim amount |
| PM-JAY or state scheme eligibility | May cover treatment at empanelled hospitals |
You are not obliged to share your diagnosis in detail, but informing your employer often makes it easier to arrange leave, flexible hours or remote work during treatment.
Your risk of recurrence depends on your stage, subtype and completion of treatment, and for most early-stage patients the risk is low and generally decreases over time.
| Cancer Type | When Recurrence Is Most Likely | What Lowers Your Risk |
|---|---|---|
| Triple-negative | Mainly within the first 3–5 years | Completing chemotherapy and any post-surgery treatment |
| HER2-positive | Mainly within the first 5 years | Completing about one year of HER2-targeted therapy |
| Hormone-positive | Can occur even 10–20 years later | Taking hormone tablets for the full recommended duration |
Major guidelines, including ASCO and NCCN, do not recommend routine PET-CT scans or tumour marker tests for patients without symptoms, as studies have not shown that they help people live longer.
| Time After Treatment | Clinical Check-Up | Imaging | Other Checks |
|---|---|---|---|
| Years 1–3 | Every 3–6 months | Mammogram every year | As needed for symptoms or treatment side effects |
| Years 4–5 | Every 6–12 months | Mammogram every year | Bone density scans if on aromatase inhibitors |
| After 5 years | Once a year | Mammogram every year | Gynaecological review if on tamoxifen |
Contact your oncology team if you notice any new symptom that lasts more than 2 weeks without an obvious cause.
Most breast cancer survivors return to work, family life and the activities they enjoy, although adjusting to a “new normal” often takes time.
Survival with metastatic breast cancer varies widely by subtype and response to treatment, and with newer therapies many patients live for several years with good quality of life.
| Metastatic Subtype | Main Treatments | General Outlook |
|---|---|---|
| Hormone-positive, HER2-negative | Hormone therapy with CDK4/6 inhibitors, then other targeted drugs | Often several years of disease control |
| HER2-positive | HER2-targeted drugs and antibody-drug conjugates | Often several years of disease control |
| Triple-negative | Chemotherapy, immunotherapy, antibody-drug conjugates | Generally shorter, though newer drugs are improving results |
Averages cannot predict how long any individual will live. Your oncologist can discuss your situation openly when you are ready.
For many patients, treatment for metastatic breast cancer can shrink tumours, ease symptoms such as pain and breathlessness, and help them live longer with better quality of life.
